27,831
Views
117
CrossRef citations to date
0
Altmetric
Reviews

Nipah virus: epidemiology, pathology, immunobiology and advances in diagnosis, vaccine designing and control strategies – a comprehensive review

, ORCID Icon, , , , ORCID Icon, ORCID Icon, , , ORCID Icon, , , & show all
Pages 26-55 | Received 19 Nov 2018, Accepted 06 Feb 2019, Published online: 22 Apr 2019

References

  • Abdullah S, Tan CT. 2014. Henipavirus encephalitis. Handb Clin Neurol. 123:663–670. doi:10.1016/B978-0-444-53488-0.00032-8
  • AbuBakar S, Chang LY, Ali AR, Sharifah SH, Yusoff K, Zamrod Z. 2004. Isolation and molecular identification of Nipah virus from pigs. Emerg Infect Dis. 10(12):2228–2230. doi:10.3201/eid1012.040452
  • Aljofan M. 2013. Hendra and Nipah infection: emerging paramyxoviruses. Virus Res. 177(2):119–126. doi:10.1016/j.virusres.2013.08.002
  • Ang BSP, Lim TCC, Wang L. 2018. Nipah virus infection. J Clin Microbiol. 56(6):e01875-17. doi: 10.1128/JCM.01875-17.
  • Angeletti S, Lo Presti A, Cella E, Ciccozzi M. 2016. Molecular epidemiology and phylogeny of Nipah virus infection: amini review. Asian Pac J Trop Med. 9(7):630–634. doi:10.1016/j.apjtm.2016.05.012
  • Arankalle VA, Bandyopadhyay BT, Ramdasi AY, Jadi R, Patil DR, Rahman M, Majumdar M, Banerjee PS, Hati AK, Goswami RP, et al. 2011. Genomic characterization of Nipah virus, West Bengal, India. Emerging Infect. Dis. 17(5):907–909. doi:10.3201/eid1705.100968
  • Arif SM, Basher A, Quddus MR, Faiz MA. 2012. Re-emergence Nipah – a review. Mymensingh Med J. 21(4):772–779.
  • Arntzen C. 2015. Plant-made pharmaceuticals: from “Edible vaccines” to Ebola therapeutics. Plant. Plant Biotechnol. J. 13(8):1013–1016. doi:10.1111/pbi.12460
  • Arunkumar G, Chandni R, Mourya DT, Singh SK, Sadanandan R, Sudan P, Bhargava B. 2018. Outbreak investigation of Nipah Virus Disease in Kerala, India. 2018. J Infect Dis. doi: 10.1093/infdis/jiy612. [Epub ahead of print]
  • Basler CF. 2012. Nipah and Hendra virus interactions with the innate immune system. Curr Top Microbiol Immunol. 359:123–152. doi: 10.1007/82_2012_209.
  • Bellini WJ, Harcourt BH, Bowden N, Rota PA. 2005. Nipah virus: an emergent paramyxovirus causing severe encephalitis in humans. J Neurovirol. 11(5):481–487. doi:10.1080/13550280500187435
  • Bhatia R, Narain JP. 2010. Review paper: the challenge of emerging zoonoses in Asia pacific. Asia Pac J Public Health. 22(4):388–394. doi:10.1177/1010539510370908
  • Bird BH, Mazet JAK. 2018. Detection of emerging zoonotic pathogens: an integrated One Health approach. Annu Rev Anim Biosci. 6(1):121–139. doi:10.1146/annurev-animal-030117-014628
  • Blum LS, Khan R, Nahar N, Breiman RF. 2009. In-depth assessment of an outbreak of Nipah encephalitis with person-to-person transmission in Bangladesh: implications for prevention and control strategies. Am J Trop Med Hyg. 80(1):96–102. doi:10.4269/ajtmh.2009.80.96
  • Bossart KN, Crameri G, Dimitrov AS, Mungall BA, Feng Y-R, Patch JR, Choudhary A, Wang L-F, Eaton BT, Broder CC. 2005. Receptor binding, fusion inhibition and induction of cross-reactive neutralizing antibodies by a soluble G glycoprotein of Hendra virus. J Virol. 79(11):6690–6702. doi:10.1128/JVI.79.11.6690-6702.2005
  • Bossart KN, Broder CC. 2006. Developments towards effective treatments for Nipah and Hendra virus infection. Expert Rev anti Infect Ther. 4(1):43–55. doi:10.1586/14787210.4.1.43
  • Bossart KN, McEachern JA, Hickey AC, Choudhry V, Dimitrov DS, Eaton BT, Wang LF. 2007. Neutralization assays for differential henipa virus serology using Bio-Plex protein array systems. J Virol Meth. 142(1–2):29–40. doi:10.1016/j.jviromet.2007.01.003
  • Bossart KN, Zhu Z, Middleton D, Klippel J, Crameri G, Bingham J, McEachern JA, Green D, Hancock TJ, Chan YP, et al. 2009. A neutralizing human monoclonal antibody protects against lethal disease in a new ferret model of acute Nipah virus infection. PLoS Pathog. 5(10):e1000642. doi:10.1371/journal.ppat.1000642
  • Bourgarel M, Pfukenyi DM, Boué V, Talignani L, Chiweshe N, Diop F, Caron A, Matope G, Missé D, Liégeois F. 2018. Circulation of Alphacoronavirus, Betacoronavirus and Paramyxovirus in Hipposideros bat species in Zimbabwe. Infect Genet Evol. 58:253–257. doi:10.1016/j.meegid.2018.01.007
  • Brass VH, Astuto-Gribble L, Finley MR. 2017. Biosafety and biosecurity in veterinary laboratories. Rev Sci Tech OIE. 36(2):701–709. doi:10.20506/rst.36.2.2687
  • Breed AC, Meers J, Sendow I, Bossart KN, Barr JA, Smith I, Wacharapluesadee S, Wang L, Field HE. 2013. The distribution of henipaviruses in Southeast Asia and Australasia: is Wallace's line a barrier to Nipah virus? PLoS One. 8(4):e61316. doi:10.1371/journal.pone.0061316
  • Broder CC, Geisbert TW, Xu K, Nikolov DB, Wang LF, Middleton D, Pallister J, Bossart KN. 2012. Immunization strategies against henipaviruses. Curr Top Microbiol Immunol. 359:197–223. doi: 10.1007/82_2012_213.
  • Broder CC, Xu K, Nikolov DB, Zhu Z, Dimitrov DS, Middleton D, Pallister J, Geisbert TW, Bossart KN, Wang L-F. 2013. A treatment for and vaccine against the deadly Hendra and Nipah viruses. Antiviral Res. 100(1):8–13. doi:10.1016/j.antiviral.2013.06.012
  • Broder CC, Weir DL, Reid PA. 2016. Hendra virus and Nipah virus animal vaccines. Vaccine. 34(30):3525–3534. doi:10.1016/j.vaccine.2016.03.075
  • CDC. 1999a. Outbreak of Hendra-like virus- Malaysia and Singapore, 1998–1999. Morb Mortal Wkly. Rep. 48:265–269.
  • CDC. 1999b. Update: outbreak of Nipah virus- Malaysia and Singapore, 1999. Morb Mortal Wkly Rep. 48:325–337.
  • Chadha MS, Comer JA, Lowe L, Rota PA, Rollin PE, Bellini WJ, Ksiazek TG, Mishra AC. 2006. Nipah-virus associated encephalitis outbreak, Siliguri, India. Emerg Infect Dis. 12(2):235–240. doi:10.3201/eid1202.051247
  • Chakraborty S. 2012. Prevalence of Nipah viral infection in Asiatic region- an overview. Int J Trop Med Pub Health. 1(1):6–10.
  • Chan YP, Chua KB, Koh CL, Lim ME, Lam SK. 2001. Complete nucleotide sequences of Nipah virus isolates from Malaysia. J Gen Virol. 82(Pt 9):2151–2155. doi:10.1099/0022-1317-82-9-2151
  • Chanchal DK, Alok S, Sabharwal M, Bijauliya RK, Rashi S. 2018. Nipah: silently rising infection. Int J Pharm Sci Res. 9(8):3128–3135. doi: 10.13040/IJPSR.0975-8232.9(8).3128-35.
  • Chang LY, Ali AR, Hassan SS, AbuBakar S. 2006. Quantitative estimation of Nipah virus replication kinetics in vitro. Virol J. 3:47.
  • Chatterjee P. 2018. Nipah virus outbreak in India. Lancet. 391(10136):2200. doi:10.1016/S0140-6736(18)31252-2
  • Chattopadhyay A, Rose JK. 2011. Complementing defective viruses that express separate paramyxovirus glycoproteins provide a new vaccine vector approach. J Virol. 85(5):2004–2011. doi:10.1128/JVI.01852-10
  • Chattu VK, Kumar R, Kumary S, Kajal F, David JK. 2018. Nipah virus epidemic in southern India and emphasizing "One Health" approach to ensure global health security. J Family Med Prim Care. 7(2):275–283. doi:10.4103/jfmpc.jfmpc_137_18
  • Chen JM, Yu M, Morrissy C, Zhao YG, Meehan G, Sun YX, Wang QH, Zhang W, Wang LF, Wang ZL. 2006. A comparative indirect ELISA for the detection of Henipavirus antibodies based on a recombinant nucleocapsid protein expressed in Escherichia coli. J Virol Methods. 136(1–2):273–276. doi:10.1016/j.jviromet.2006.05.003
  • Chiang CF, Lo MK, Rota PA, Spiropoulou CF, Rollin PE. 2010. Use of monoclonal antibodies against Hendra and Nipah viruses in an antigen capture-ELISA. Virol J. 7(1):115. doi:10.1186/1743-422X-7-115
  • Chong HT, Tan CT. 2003. Relapsed and late-onset Nipah encephalitis, a report of three cases. Neurol J Southeast Asia. 8:109–112.
  • Chowdhury SS, Khan U, Crameri G, Epstein JH, Broder CC, Islam A, Peel AJ, Barr J, Daszak P, Wang LF, Luby SP. 2014. Serological evidence of henipavirus exposure in cattle, goats and pigs in Bangladesh. PLoS Negl Trop Dis. 8(11):e3302–25412358. PMID: doi:10.1371/journal.pntd.0003302
  • Chua KB, Goh KJ, Wong KT, Kamarulzaman A, Tan PS, Ksiazek TG, Zaki SR, Paul G, Lam SK, Tan CT. 1999. Fatal encephalitis due to Nipah virus among pig-farmers in Malaysia. Lancet. 354(9186):1257–1259. doi:10.1016/S0140-6736(99)04299-3
  • Chua KB. 2003. Nipah virus outbreak in Malaysia. J Clin Virol. 26(3):265–275. doi:10.1016/S1386-6532(02)00268-8
  • Chua KB. 2010. Epidemiology, surveillance and control of Nipah virus infections in Malaysia. Malays J Pathol. 32(2):69–73.
  • Chua KB. 2012. Introduction: Nipah virus-discovery and origin. Curr Top Microbiol Immunol. 359:1–9. doi: 10.1007/82_2012_218.
  • Chua KB, Bellini WJ, Rota PA, Harcourt BH, Lam SK, Ksiazek TG, Rollin PE, Zaki SR, Shieh WJ, Goldsmith CS, et al. 2000. Nipah virus: a recently emergent deadly paramyxovirus. Science. 288(5470):1432–1435. doi:10.1126/science.288.5470.1432
  • Chua KB, Lam SK, Goh KJ, Hooi PS, Ksiazek TG, Kamarulzaman A, Olson J, Tan CT. 2001. The presence of Nipah virus in respiratory secretions and urine of patients during an outbreak of Nipah virus encephalitis in Malaysia. J Infect. 42(1):40–43. doi:10.1053/jinf.2000.0782
  • Chua KB, Koh CL, Hooi PS, Wee KF, Khong JH, Chua BH, Chan YP, Lim ME, Lam SK. 2002. Isolation of Nipah virus from Malaysian Island flying-foxes. Microbes Infect. 4(2):145–151. doi:10.1016/S1286-4579(01)01522-2
  • Ciancanelli MJ, Basler CF. 2006. Mutation of YMYL in the Nipah virus matrix protein abrogates budding and alters subcellular localization. J Virol. 80(24):12070–12078. doi:10.1128/JVI.01743-06
  • Clayton BA, Middleton D, Arkinstall R, Frazer L, Wang L-F, Marsh GA. 2016. The nature of exposure drives transmission of Nipah viruses from Malaysia and Bangladesh in ferrets. PLoS Negl Trop Dis. 10(6):e0004775. doi:10.1371/journal.pntd.0004775
  • Clayton BA. 2017. Nipah virus: transmission of a zoonotic paramyxovirus. Curr Opin Virol. 22:97–104. doi:10.1016/j.coviro.2016.12.003
  • Cortes MC, Cauchemez S, Lefrancq N, Luby SP, Jahangir Hossain M, Sazzad HMS, Rahman M, Daszak P, Salje H, Gurley ES. 2018. Characterization of the spatial and temporal distribution of Nipah virus spillover events in Bangladesh, 2007-2013. J Infect Dis. 217(9):1390–1394. doi:10.1093/infdis/jiy015
  • Daniels P, Ksiazek T, Eaton BT. 2001. Laboratory diagnosis of Nipah and Hendra virus infections. Microbes Infect. 3(4):289–295. doi:10.1016/S1286-4579(01)01382-X
  • Dasgupta A, Hammarlund E, Slifka MK, Fruh K. 2007. Cowpox virus evades CTL recognition and inhibits the intracellular transport of MHC class I molecules. J Immunol. 178(3):1654–1661. doi:10.4049/jimmunol.178.3.1654
  • Daszak P, Zambrana-Torrelio C, Bogich TL, Fernandez M, Epstein JH, Murray KA, Hamilton H. 2013. Interdisciplinary approaches to understanding disease emergence: the past, present, and future drivers of Nipah virus emergence. Proc Natl Acad Sci USA. 110(Supplement_1):3681–3688. doi:10.1073/pnas.1201243109
  • Dawes BE, Kalveram B, Ikegami T, Juelich T, Smith JK, Zhang L, Park A, Lee B, Komeno T, Furuta Y, Freiberg AN. 2018. Favipiravir (T-705) protects against Nipah virus infection in the hamster model. Sci Rep. 8(1):7604. doi:10.1038/s41598-018-25780-3
  • DeBuysscher BL, Scott D, Marzi A, Prescott J, Feldmann H. 2014. Single-dose live-attenuated Nipah virus vaccines confer complete protection by eliciting antibodies directed against surface glycoproteins. Vaccine. 32(22):2637–2644. doi:10.1016/j.vaccine.2014.02.087
  • DeBuysscher BL, Scott D, Thomas T, Feldmann H, Prescott J. 2016. Peri-exposure protection against Nipah virus disease using a single-dose recombinant vesicular-stomatitis virus-based vaccine. NPJ Vaccines. 1:16002. doi:10.1038/npjvaccines.2016.2
  • de Wit E, Bushmaker T, Scott D, Feldmann H, Munster VJ. 2011. Nipah virus transmission in a hamster model. PLoS Negl Trop Dis. 5(12):e1432. doi:10.1371/journal.pntd.0001432
  • de Wit E, Prescott J, Falzarano D, Bushmaker T, Scott D, Feldmann H, Munster VJ. 2014. Foodborne transmission of Nipah virus in Syrian hamsters. PLoS Pathog. 10(3):e1004001. doi:10.1371/journal.ppat.1004001
  • de Wit E, Munster VJ. 2015a. Nipah virus emergence, transmission, and pathogenesis. In: Shapshak P, Sinnott J, Somboonwit C, Kuhn J, editors. Global virology I – identifying and investigating viral diseases. New York, NY: Springer; p. 125–146.
  • de Wit E, Munster VJ. 2015. Animal models of disease shed light on Nipah virus pathogenesis and transmission. J Pathol. 235(2):196–205. doi:10.1002/path.4444
  • Defang GN, Khetawat D, Broder CC, Quinnan GV, Jr.2010. Induction of neutralizing antibodies to Hendra and Nipah glycoproteins using a Venezuelan equine encephalitis virus in vivo expression system. Vaccine. 29(2):212–220. doi:10.1016/j.vaccine.2010.10.053
  • Deka MA, Morshed N. 2018. Mapping disease transmission risk of Nipah virus in South and Southeast Asia. Tropical Med. 3(2):57. doi: 10.3390/tropicalmed3020057.
  • Dhama K, Chakraborty S, Kapoor S, Tiwari R, Kumar A, Deb R, Rajagunalan S, Singh R, Vora K, Natesan S. 2013a. One world, one health – veterinary perspectives. Adv Anim Vet Sci. 1(1):5–13.
  • Dhama K, Chakraborty S, Wani MY, Tiwari R, Barathidasan R. 2013b. Cytokine therapy for combating animal and human diseases – a review. Res Opin AnimVet Sci. 3(7):195–208.
  • Dhama K, Chakrabort SM, Wani MY, Verma AK, Deb R, Tiwari R, Kapoor S. 2013. Novel and emerging therapies safeguarding health of humans and their companion animals: a review. Pakistan J Biol Sci. 16(3):101–111. doi:10.3923/pjbs.2013.101.111
  • Dhama K, Wani MY, Deb R, Karthik K, Tiwari R, Barathidasan R, Kumar A, Mahima VAK, Singh SD. 2013d. Plant based oral vaccines for human and animal pathogens – a new era of prophylaxis: current and future perspectives. J Exp Biol Agri Sci. 1(1):1–12.
  • Dhama K, Chakraborty S, Tiwari R, Verma AK, Saminathan M, Amarpal Malik YS, Nikousefat Z, Javdani M, Khan RU. 2014. A concept paper on novel technologies boosting production and safeguarding health of humans and animals. Res Opin Anim Vet Sci. 4(7):353–370.
  • Dhama K, Karthik K, Khandia R, Munjal A, Tiwari R, Rana R, Khurana SK, Sana U, Khan RU, Alagawany M, et al. 2018a. Medicinal and therapeutic potential of herbs and plant metabolites/extracts countering viral pathogens- current knowledge and future prospects. Curr Drug Metab. 19(3):236–263. doi:10.2174/1389200219666180129145252
  • Dhama K, Karthik K, Tiwari R, Khandia R, Munjal A, Chakraborty S, Yadav JP, Kumar D, Latheef SK, Saminathan M, et al. 2018b. Zika virus/Zika fever: a comprehensive update. J Exp Biol Agri Sci. 6(1):1–31.
  • Dhama K, Karthik K, Khandia R, Chakraborty S, Munjal A, Latheef SK, Kumar D, Ramakrishnan MA, Malik YS, Singh R, et al. 2018c. Advances in designing and developing vaccines, drugs, and therapies to counter Ebola virus. Front Immunol. 9:1803. doi:10.3389/fimmu.2018.01803
  • Donaldson H, Lucey D. 2018. Enhancing preparation for large Nipah outbreaks beyond Bangladesh: preventing a tragedy like Ebola in West Africa. Int J Infect Dis. 72:69–72. doi:10.1016/j.ijid.2018.05.015
  • Eaton BT, Broder CC, Wang LF. 2005. Hendra and Nipah viruses: pathogenesis and therapeutics. Curr Mol Med. 5(8):805–816. doi:10.2174/156652405774962308
  • Eaton BT, Broder CC, Middleton D, Wang LF. 2006. Hendra and Nipah viruses: different and dangerous. Nat Rev Microbiol. 4(1):23–35. doi:10.1038/nrmicro1323
  • Enchéry F, Horvat B. 2017. Understanding the interaction between henipaviruses and their natural host, fruit bats: Paving the way toward control of highly lethal infection in humans. Int Rev Immunol. 36(2):108–121. doi:10.1080/08830185.2016.1255883
  • Epstein JH, Field HE, Luby S, Pulliam JR, Daszak P. 2006. Nipah virus: impact, origins, and causes of emergence. Curr Infect Dis Rep. 8(1):59–65. doi:10.1007/s11908-006-0036-2
  • Epstein JH, Prakash V, Smith CS, Daszak P, McLaughlin AB, Meehan G, Field HE, Cunningham AA. 2008. Henipavirus infection in fruit bats (Pteropus giganteus), India. Emerging Infect Dis. 14(8):1309–1311. doi:10.3201/eid1408.071492
  • Escaffre O, Borisevich V, Rockx B. 2013. Pathogenesis of Hendra and Nipah virus infection in humans. J Infect Dev Ctries. 7(4):308–311. doi: 10.3855/jidc.3648
  • Escaffre O, Hill T, Ikegami T, Juelich TL, Smith JK, Zhang L, Perez DE, Atkins C, Park A, Lawrence WS, et al. 2018. Experimental infection of Syrian hamsters with aerosolized Nipah virus. J Infect Dis. 218(10):1602–1610. doi:10.1093/infdis/jiy357
  • Eshaghi M, Tan WS, Mohidin TB, Yusoff K. 2004. Nipah virus glycoprotein: production in baculovirus and application in diagnosis. Virus Res. 106(1):71–76. doi:10.1016/j.virusres.2004.06.011
  • Farrar JJ. 1999. Nipah-virus encephalitis-investigation of a new infection. Lancet. 354(9186):1222–1223. doi:10.1016/S0140-6736(99)90124-1
  • Field H, de Jong CE, Halpin K, Smith CS. 2013. Henipaviruses and fruit bats, Papua New Guinea. Emerging Infect Dis. 19(4):670–671. doi:10.3201/eid1904.111912
  • Fischer K, Diederich S, Smith G, Reiche S, Pinho Dos Reis V, Stroh E, Groschup MH, Weingartl HM, Balkema-Buschmann A. 2018. Indirect ELISA based on Hendra and Nipah virus proteins for the detection of henipavirus specific antibodies in pigs. PLoS One. 13(4):e0194385. doi:10.1371/journal.pone.0194385
  • Fogarty R, Halpin K, Hyatt AD, Daszak P, Mungall BA. 2008. Henipavirus susceptibility to environmental variables. Virus Res. 132(1–2):140–144. doi:10.1016/j.virusres.2007.11.010
  • Geisbert TW, Feldmann H, Broder CC. 2012. Animal challenge models of Henipavirus infection and pathogenesis. Curr Top Microbiol Immunol. 359:153–177. doi: 10.1007/82_2012_208.
  • Geisbert TW, Mire CE, Geisbert JB, Chan YP, Agans KN, Feldmann F, Fenton KA, Zhu Z, Dimitrov DS, Scott DP, et al. 2014. Therapeutic treatment of Nipah virus infection in nonhuman primates with a neutralizing human monoclonal antibody. Sci Transl Med. 6(242):242ra82. doi:10.1126/scitranslmed.3008929
  • Glennon EE, Restif O, Sbarbaro SR, Garnier R, Cunningham AA, Suu-Ire RD, Osei-Amponsah R, Wood JLN, Peel AJ. 2018. Domesticated animals as hosts of henipaviruses and filoviruses: a systematic review. Vet J. 233:25–34. doi:10.1016/j.tvjl.2017.12.024
  • Giangaspero M. 2013. Nipah virus. Trop Med Surg. 1:4. http://dx.doi.org/10.4172/2329-9088.1000129
  • Goh KJ, Tan CT, Chew NK, Tan PS, Kamarulzaman A, Sarji SA, Wong KT, Abdullah BJ, Chua KB, Lam SK, 2000. Clinical features of Nipah virus encephalitis among pig farmers in Malaysia. N Engl J Med. 342(17):1229–1235. doi:10.1056/NEJM200004273421701
  • Guillaume V, Lefeuvre A, Faure C, Marianneau P, Buckland R, Lam SK, Wild TF, Deubel V, 2004. Specific detection of Nipah virus using real-time RT-PCR (TaqMan). J Virol Methods. 120(2):229–237. doi:10.1016/j.jviromet.2004.05.018
  • Guillaume V, Contamin H, Loth P, Georges-Courbot MC, Lefeuvre A, Marianneau P, Chua KB, Lam SK, Buckland R, Deubel V, Wild TF. 2004. Nipah virus: vaccination and passive protection studies in a hamster model. J Virol. 78(2):834–840. doi:10.1128/JVI.78.2.834-840.2004
  • Guillaume V, Contamin H, Loth P, Grosjean I, Courbot MC, Deubel V, Buckland R, Wild TF, 2006. Antibody prophylaxis and therapy against Nipah virus infection in hamsters. J Virol. 80(4):1972–1978. doi:10.1128/JVI.80.4.1972-1978.2006
  • Guillaume V, Wong KT, Looi RY, Georges-Courbot MC, Barrot L, Buckland R, Wild TF, Horvat B. 2009. Acute Hendra virus infection: analysis of the pathogenesis and passive antibody protection in the hamster model. Virology. 387(2):459–465. doi:10.1016/j.virol.2009.03.001
  • Gurley ES, Montgomery JM, Hossain MJ, Bell M, Azad AK, Islam MR, Molla MA, Carroll DS, Ksiazek TG, Rota PA, Lowe L, et al. 2007. Person-to-person transmission of Nipah virus in a Bangladeshi community. Emerg Infect Dis. 13(7):1031–1037. doi:10.3201/eid1307.061128
  • Gurley ES, Hegde ST, Hossain K, Sazzad HMS, Hossain MJ, Rahman M, Sharker MAY, Salje H, Islam MS, Epstein JH, et al. 2017. Convergence of humans, bats, trees, and culturein Nipah virus transmission, Bangladesh. Emerg Infect Dis. 23(9):1446–1453. doi:10.3201/eid2309.161922
  • Halpin K, Young PL, Field HE, Mackenzie JS. 2000. Isolation of Hendra virus from pteropid bats: a natural reservoir of Hendra virus. J Gen Virol. 81(Pt 8):1927–1932. PMID 10900029. doi:10.1099/0022-1317-81-8-1927
  • Halpin K, Hyatt AD, Fogarty R, Middleton D, Bingham J, Epstein JH, Rahman SA, Hughes T, Smith C, Field HE, Daszak P, The Henipavirus Ecology Research Group. 2011. Pteropid bats are confirmed as the reservoir hosts of henipaviruses: a comprehensive experimental study of virus transmission. Am J Trop Med Hyg. 85(5):946–951. doi:10.4269/ajtmh.2011.10-0567
  • Harcourt BH, Lowe L, Tamin A, Liu X, Bankamp B, Bowden N, Rollin PE, Comer JA, Ksiazek TG, Hossain MJ, et al. 2005. Genetic characterization of Nipah virus, Bangladesh, 2004. Emerging Infect Dis. 11(10):1594–1597. doi:10.3201/eid1110.050513
  • Harit AK, Ichhpujani RL, Gupta S, Gill KS, Lal S, Ganguly NK, Agarwal SP. 2006. Nipah/Hendra virus outbreak in Siliguri, West Bengal, India in 2001. Indian J Med Res. 123(4):553–560.
  • Hasebe F, Thuy NTT, Inoue S, Yu F, Kaku Y, Watanabe S, Akashi H, Dat DT, Mai LTQ, Morita K. 2012. Serologic evidence of Nipah virus infection in bats, Vietnam. Emerging Infect Dis. 18(3):536–537. doi:10.3201/eid1803.111121
  • Hassan MZ, Sazzad HMS, Luby SP, Sturm-Ramirez K, Bhuiyan MU, Rahman MZ, Islam MM, Ströher U, Sultana S, Kafi MAH, et al. 2018. Nipah virus contamination of hospital surfaces during outbreaks, Bangladesh, 2013-2014. Emerg Infect Dis. 24(1):15–21. doi:10.3201/eid2401.161758
  • Hayman DTS, Suu-Ire R, Breed AC, McEachern JA, Wang L, Wood JLN, Cunningham AA. 2008. Evidence of Henipavirus infection in West African fruit bats. PLoS One. 3(7):e2739. doi:10.1371/journal.pone.0002739
  • Hayman DTS, Wang LF, Barr J, Baker KS, Suu-Ire R, Broder CC, Cunningham AA, Wood JLN. 2011. Antibodies to Henipavirus or Henipa-Like viruses in domestic pigs in Ghana, West Africa. PLoS One. 6(9):e25256. doi:10.1371/journal.pone.0025256
  • Hegde ST, Sazzad HM, Hossain MJ, Alam MU, Kenah E, Daszak P, Rollin P, Rahman M, Luby SP, Gurley ES, 2016. Investigating rare risk factors for Nipah virus in Bangladesh: 2001-2012. Ecohealth. 13(4):720–728. doi:10.1007/s10393-016-1166-0
  • Hoffmann M, Nehlmeier I, Brinkmann C, Krähling V, Behner L, Moldenhauer AS, Krüger N, Nehls J, Schindler M, Hoenen T, et al. 2018. Tetherin inhibits Nipah virus but not Ebola virus replication in fruit bat cells. J Virol. 93(3):pii:e01821-18. doi: 10.1128/JVI.01821-18.
  • Homaira N, Rahman M, Hossain MJ, Epstein JH, Sultana R, Khan MS, Podder G, Nahar K, Ahmed B, Gurley ES, et al. 2010. Nipah virus outbreak with person-to-person transmission in a district of Bangladesh, 2007. Epidemiol Infect. 138(11):1630–1636. doi:10.1017/S0950268810000695
  • Homaira N, Rahman M, Hossain MJ, Nahar N, Khan R, Rahman M, Podder G, Nahar K, Khan D, Gurley ES, et al. 2010. Cluster of Nipah virus infection, Kushtia District, Bangladesh, 2007. PLoS One. 5(10):e13570. doi:10.1371/journal.pone.0013570
  • Hossain MJ, Gurley ES, Montgomery JM, Bell M, Carroll DS, Hsu VP, Formenty P, Croisier A, Bertherat E, Faiz Abul Kalam Azad MA, et al. 2008. Clinical presentation of Nipah virus infection in Bangladesh. Clin Infect Dis. 46(7):977–984. doi:10.1086/529147
  • Hsu VP, Hossain MJ, Parashar UD, Ali MM, Ksiazek TG, Kuzmin I, Niezgoda M, Rupprecht C, Bresee J, Breiman RF, 2004. Nipah virus encephalitis reemergence, Bangladesh. Emerging Infect Dis. 10(12):2082–2087. doi:10.3201/eid1012.040701
  • http://gvn.org/update-on-the-nipah-virus-outbreak-in-kerala-india/
  • https://indianexpress.com/article/india/nipah-virus-outbreak-in-kerala-everything-you-need-to-know-5194341/
  • https://www.ndtv.com/health/nipah-virus-some-preventive-measures-for-nipah-virus-1855891.
  • Hughes JM, Wilson ME, Luby SP, Gurley ES, Hossain MJ. 2009. Transmission of human infection with Nipah virus. Clin Infect Dis. 49(11):1743–1748. doi:10.1086/647951
  • ICDDRB. 2003. Outbreaks of encephalitis due to Nipah/Hendra-like viruses, western Bangladesh. Health Sci Bull. 11:1–6.
  • ICDDRB. 2010. Nipah Outbreak in Faridpur District, Bangladesh. Health Sci Bull. 8:6–11.
  • ICDDRB. 2011. Nipah outbreak in Lalmonirhat district. Health Sci Bull. 9(2):13–18.
  • Islam MS, Sazzad HM, Satter SM, Sultana S, Hossain MJ, Hasan M, Rahman M, Campbell S, Cannon DL, Ströher U, et al. 2016. Nipah virus transmission from bats to humans associated with drinking traditional liquor made from date palm sap, Bangladesh, 2011-2014. Emerg Infect Dis. 22(4):664–670. doi:10.3201/eid2204.151747
  • Jegerlehner A, Tissot A, Lechner F, Sebbel P, Erdmann I, Kündig T, Bächi T, Storni T, Jennings G, Pumpens P, et al. 2002. A molecular assembly system that renders antigens of choice highly repetitive for induction of protective B cell responses. Vaccine. 20(25–26):3104–3112. doi:10.1016/S0264-410X(02)00266-9
  • Jennings GT, Bachmann MF. 2007. Designing recombinant vaccines with viral properties: a rational approach to more effective vaccines. Curr Mol Med. 7(2):143–155. doi:10.2174/156652407780059140
  • Jensen KS, Adams R, Bennett RS, Bernbaum J, Jahrling PB, Holbrook MR. 2018. Development of a novel real-time polymerase chain reaction assay for the quantitative detection of Nipah virus replicative viral RNA. PLoS One. 13(6):e0199534. doi:10.1371/journal.pone.0199534
  • Johnston GP, Contreras EM, Dabundo J, Henderson BA, Matz KM, Ortega V, Ramirez A, Park A, Aguilar HC. 2017. Cytoplasmic motifs in the Nipah virus fusion protein modulate virus particle assembly and egress. J Virol. 91(10):pii: e02150-16. doi: 10.1128/JVI.02150-16.
  • Kaku Y, Noguchi A, Marsh GA, Barr JA, Okutani A, Hotta K, Bazartseren B, Broder CC, Yamada A, Inoue S, Wang LF. 2012. Antigens capture ELISA system for Henipaviruses using polyclonal antibodies obtained by DNA immunization. Arch Virol. 157(8):1605–1609. doi:10.1007/s00705-012-1338-3
  • Kamthania M, Sharma DK. 2015. Screening and structure-based modeling of T-cell epitopes of Nipah virus proteome: an immunoinformatic approach for designing peptide-based vaccine. 3 Biotech. 5(6):877–882. Epub 2015 May 19. doi:10.1007/s13205-015-0303-8
  • Kari K, Liu W, Gautama K, Mammen MP, Clemens JD, Nisalak A, Subrata K, Kim HK, Xu Z-Y. 2006. A hospital-based surveillance for Japanese encephalitis in Bali, Indonesia. BMC Med. 4:8. doi:10.1186/1741-7015-4-8
  • Kessler MK, Becker DJ, Peel AJ, Justice NV, Lunn T, Crowley DE, Jones DN, Eby P, Sánchez CA, Plowright RK. 2018. Changing resource landscapes and spillover of henipaviruses. Ann N Y Acad Sci. 1429(1):78–99. doi:10.1111/nyas.13910
  • Khan M, Nahar N, Sultana R, Hossain M, Gurley ES, Luby S. 2008. Understanding bats access to date palm sap: identifying preventative techniques for Nipah virus transmission. New Orleans AmSocTrop Med Hyg. 4(3):331–333.
  • Khan MS, Hossain J, Gurley ES, Nahar N, Sultana R, Luby SP. 2010. Use of infrared camera to understand bats’ access to date palm sap: implications for preventing Nipah virus transmission. EcoHealth. 7(4):517–525. doi:10.1007/s10393-010-0366-2
  • Kitsutani P, Ohta M. 2005. Nipah virus infections. Nippon Rinsho. 63(12):2143–2153.
  • Kong D, Wen Z, Su H, Ge J, Chen W, Wang X, Wu C, Yang C, Chen H, Bu Z. 2012. Newcastle disease virus-vectored Nipah encephalitis vaccines induce B and T cell responses in mice and long-lasting neutralizing antibodies in pigs. Virology. 432(2):327–335. doi:10.1016/j.virol.2012.06.001
  • Ksiazek TG, Rota PA, Rollin PE. 2011. A review of Nipah and Hendra viruses with an historical aside. Virus Res. 62(1–2):173–183. doi: 10.1016/j.virusres.2011.09.026.
  • Kulkarni DD, Tosh C, Venkatesh G, Senthil Kumar D. 2013. Nipah virus infection: current scenario. Indian J Virol. 24(3):398–408. doi:10.1007/s13337-013-0171-y
  • Kumar N, Kulkarni DD, Lee B, Kaushik R, Bhatia S, Sood R, Pateriya AK, Bhat S, Singh VP. 2018. Evolution of codon usage bias in Henipaviruses is governed by natural selection and is host-specific. Viruses. 10(11) E604. doi: 10.3390/v10110604.
  • Kumar AKA, Anoop Kumar AS. 2018. Deadly Nipah outbreak in Kerala: lessons learned for the future. Indian J Crit Care Med. 22(7):475–476. doi:10.4103/ijccm.IJCCM_282_18
  • Kurup D, Wirblich C, Feldmann H, Marzi A, Schnell MJ. 2015. Rhabdovirus-based vaccine platforms against henipaviruses. J Virol. 89(1):144–154. doi:10.1128/JVI.02308-14
  • Li M, Embury-Hyatt C, Weingartl HM. 2010. Experimental inoculation study indicates swine as a potential host for Hendra virus. Vet Res. 41(3):33. doi:10.1051/vetres/2010005
  • Lim CC, Lee KE, Lee WL, Tambyah PA, Lee CC, Sitoh YY, Auchus AP, Lin BK, Hui F. 2002. Nipah virus encephalitis: serial MR study of an emerging disease. Radiology. 222(1):219–226. doi:10.1148/radiol.2221010499
  • Liu F, Wu X, Li L, Liu Z, Wang Z. 2013. Use of baculovirus expression system for generation of virus-like particles: successes and challenges. Protein Expr Purif. 90(2):104–116. doi:10.1016/j.pep.2013.05.009
  • Liu Q, Bradel-Tretheway B, Monreal AI, Saludes JP, Lu X, Nicola AV, Aguilar HC. 2015. Nipah virus attachment clycoprotein stalk C-terminal region links receptor binding to fusion triggering. J Virol. 89(3):1838–1850. doi:10.1128/JVI.02277-14
  • Liu Q, Chen L, Aguilar HC, Chou KC. 2018. A stochastic assembly model for Nipah virus revealed by super-resolution microscopy. Nat Commun. 9(1):3050. doi:10.1038/s41467-018-05480-2
  • Lo MK, Rota PA. 2008. The emergence of Nipah virus, a highly pathogenic paramyxovirus. J Clin Virol. 43(4):396–400. doi:10.1016/j.jcv.2008.08.007
  • Lo MK, Miller D, Aljofan M, Mungall BA, Rollin PE, Bellini WJ, Rota PA. 2010. Characterization of the antiviral and inflammatory responses against Nipah virus in endothelial cells and neurons. Virology. 404(1):78–88. doi:10.1016/j.virol.2010.05.005
  • Lo MK, Lowe L, Hummel KB, Sazzad HMS, Gurley ES, Jahangir Hossain M, Luby SP, Miller DM, Comer JA, Rollin PE, et al. 2012. Characterization of Nipah virus from outbreaks in Bangladesh, 2008-2010. Emerging Infect Dis. 18(2):248–255. doi:10.3201/eid1802.111492
  • Lo MK, Bird BH, Chattopadhyay A, Drew CP, Martin BE, Coleman JD, Rose JK, Nichol ST, Spiropoulou CF. 2014. Single-dose replication-defective VSV-based Nipah virus vaccines provide protection from lethal challenge in Syrian hamsters. Antiviral Res. 101:26–29. doi:10.1016/j.antiviral.2013.10.012
  • Looi LM, Chua KB. 2007. Lessons from the Nipah virus outbreak in Malaysia. Malays J Pathol. 29(2):63–67.
  • Lo Presti A, Cella E, Giovanetti M, Lai A, Angeletti S, Zehender G, Ciccozzi M. 2016. Origin and evolution of Nipah virus. J Med Virol. 88(3):380–388. doi:10.1002/jmv.24345
  • Luby SP. 2013. The pandemic potential of Nipah virus. Antiviral Res. 100(1):38–43. doi:10.1016/j.antiviral.2013.07.011
  • Luby SP, Rahman M, Hossain MJ, Blum LS, Husain MM, Gurley E, Khan R, Ahmed BN, Rahman S, Nahar N, et al. 2006. Foodborne transmission of Nipah virus, Bangladesh. Emerging Infect Dis. 12(12):1888–1894. doi:10.3201/eid1212.060732
  • Luby SP, Hossain MJ, Gurley ES, Ahmed BN, Banu S, Khan SU, Homaira N, Rota PA, Rollin PE, Comer JA, et al. 2009. Recurrent zoonotic transmission of Nipah virus into humans, Bangladesh, 2001-2007. Emerg Infect Dis. 15(8):1229–1235. doi:10.3201/eid1508.081237
  • Luby SP, Gurley ES, Hossain MJ. 2012. Transmission of human infection with Nipah virus. In: Institute of Medicine (US). Improving Food Safety Through a One Health Approach: Workshop Summary. Washington (DC): National Academies Press (US), 2012. A11. Available from: https://www.ncbi.nlm.nih.gov/books/NBK114486/
  • Majid Z, Majid Warsi S. 2018. NIPAH virus: a new threat to South Asia. Trop Doct. 48(4):376. doi:10.1177/0049475518791327
  • Malik YS, Sharma K, Jeena LM, Kumar N, Sircar S, Rajak KK, Dhama K. 2013. Toll-like receptors: the innate immune receptors with ingenious anti-viral paradigm. South Asian J Exp Biol. 3:207–213.
  • Marsh GA, Wang LF. 2012. Hendra and Nipah viruses: why are they so deadly? Curr Opin Virol. 2(3):242–247. doi:10.1016/j.coviro.2012.03.006
  • Martinez-Gil L, Vera-Velasco NM, Mingarro I. 2017. Exploring the Human-Nipah virus protein-protein Interactome. J Virol. 91(23):e01461–e01417. doi: 10.1128/JVI.01461-17.
  • Mathieu C, Pohl C, Szecsi J, Trajkovic-Bodennec S, Devergnas S, Raoul H, Cosset FL, Gerlier D, Wild TF, Horvat B. 2011. Nipah virus uses leukocytes for efficient dissemination within a host. J Virol. 85(15):7863–7871. doi:10.1128/JVI.00549-11
  • Mathieu C, Guillaume V, Volchkova VA, Pohl C, Jacquot F, Looi RY, Wong KT, Legras-Lachuer C, Volchkov VE, Lachuer J, Horvat B. 2012. Non-structural Nipah virus C protein regulates both the early host proinflammatory response and viral virulence. J Virol. 86(19):10766–10775. doi:10.1128/JVI.01203-12
  • Mathieu C, Horvat B. 2015. Henipavirus pathogenesis and antiviral approaches. Exp Rev anti Infect Ther. 13(3):343–354. doi:10.1586/14787210.2015.1001838
  • Mathieu C, Porotto M, Figueira TN, Horvat B, Moscona A. 2018. Fusion inhibitory lipopeptides engineered for prophylaxis of Nipah virus in primates. J Infect Dis. 218(2):218–227. doi:10.1093/infdis/jiy152
  • McCormack JG. 2005. Hendra and Nipah viruses: new zoonotically-acquired human pathogens. Respir Care Clin N Am. 11(1):59–66. doi:10.1016/j.rcc.2004.10.006
  • Mire CE, Versteeg KM, Cross RW, Agans KN, Fenton KA, Whitt MA, Geisbert TW. 2013. Single injection recombinant vesicular stomatitis virus vaccines protect ferrets against lethal Nipah virus disease. Virol J. 10(1):353. doi:10.1186/1743-422X-10-353
  • Montgomery JM, Hossain MJ, Gurley E, Carroll GD, Croisier A, Bertherat E, Asgari N, Formenty P, Keeler N, Comer J, et al. 2008. Risk factors for Nipah virus encephalitis in Bangladesh. Emerging Infect Dis. 14(10):1526–1532. doi:10.3201/eid1410.060507
  • Mounts AW, Kaur H, Parashar UD, Ksiazek TG, Cannon D, Arokiasamy JT, Anderson LJ, Lye MS. 2001. Nipah Virus Nosocomial Study Group. A cohort study of health care workers to assess nosocomial transmissibility of Nipah virus. J Infect Dis. 183(5):810–813. doi:10.1086/318822
  • Mukherjee S. 2017. Emerging infectious diseases: epidemiological perspective. Indian J Dermatol. 62(5):459–467.doi: 10.4103/ijd.IJD_379_17
  • Munjal A, Khandia R, Dhama K, Sachan S, Karthik K, Tiwari R, Malik YS, Kumar D, Singh RK, Iqbal HMN, Joshi SK. 2017. Advances in developing therapies to combat Zika virus: current knowledge and future perspectives. Front Microbiol. 8:1469. doi:10.3389/fmicb.2017.01469
  • Munster VJ, Prescott JB, Bushmaker T, Long D, Rosenke R, Thomas T, Scott D, Fischer ER, Feldmann H, de Wit E. 2012. Rapid Nipah virus entry into the central nervous system of hamsters via the olfactory route. Sci Rep. 2:736. doi:10.1038/srep00736
  • Nahar N, Paul RC, Sultana R, Sumon SA, Banik KC, Abedin J, Asaduzzaman M, Garcia F, Zimicki S, Rahman M, et al. 2017. A controlled trial to reduce the risk of human Nipah virus exposure in Bangladesh. Ecohealth. 14(3):501–517. doi:10.1007/s10393-017-1267-4
  • Negrete OA, Levroney EL, Aguilar HC, Bertolotti-Ciarlet A, Nazarian R, Tajyar S, Lee B. 2005. EphrinB2 is the entry receptor for Nipah virus, an emergent deadly paramyxovirus. Nature. 436(7049):401–405. doi:10.1038/nature03838
  • National Centre for Disease Control. (NCDC). Treatment of Nipah virus. http://www.ncdc.gov.in/showfile.php/lid=241. Accessed on August 15th, 2018.
  • Nor MMN. 1999. Emergency Report by the DG, Malaysian Vet Services, OIE May 28, 1999; 12(20). Available as Animal Health Fact Sheet of California Department of Food & Agriculture (CDFA). http://www.cdfa.ca.gov/ahfss/animal_health/pdfs/nipah.pdf. Accessed on July 28th, 2007.
  • Nor MNM, Gan CH, Ong BL. 2000. Nipah virus infection of pigs in peninsular Malaysia. Rev-off Int Epizoot. 19(1):160–165.
  • Olson JG, Rupprecht C, Rollin PE, An US, Niezgoda M, Clemins T, Walston J, Ksiazek TG. 2002. Antibodies to Nipah-like virus in bats (Pteropuslylei), Cambodia. Emerging Infect Dis. 8(9):987–988. doi:10.3201/eid0809.010515
  • O'Shea TJ, Cryan PM, Cunningham AA, Fooks AR, Hayman DT, Luis AD, Peel AJ, Plowright RK, Wood JL. 2014. Bat flight and zoonotic viruses. Emerg Infect Dis. 20(5):741–745. doi:10.3201/eid2005.130539
  • Pallister J, Middleton D, Wang LF, Klein R, Haining J, Robinson R, Yamada M, White J, Payne J, Feng YR, et al. 2011. A recombinant Hendra virus G glycoprotein-based subunit vaccine protects ferrets from lethal Hendra virus challenge. Vaccine. 29(34):5623–5630. doi:10.1016/j.vaccine.2011.06.015
  • Parashar UD, Sunn LM, Ong F, Mounts AW, Arif MT, Ksiazek TG, Kamaluddin MA, Mustafa AN, Kaur H, Ding LM, et al. 2000. Case-control study of risk factors for human infection with a new zoonotic paramyxovirus, Nipah virus, during a 1998-1999 outbreak of severe encephalitis in Malaysia. J Infect Dis. 181(5):1755–1759. doi:10.1086/315457
  • Paton NI, Leo YS, Zaki SR, Auchus AP, Lee KE, Ling AE, Chew SK, Ang B, Rollin PE, Umapathi T, et al. 1999. Outbreak of Nipah-virus infection among abattoir workers in Singapore. Lancet. 354(9186):1253–1256. doi:10.1016/S0140-6736(99)04379-2
  • Paul L. 2018. Nipah virus in Kerala: a deadly zoonosis. Clin Microbiol Infect. pii: S1198-743X: (18)30480-4. doi: 10.1016/j.cmi.2018.06.017.
  • Ploquin A, Szécsi J, Mathieu C, Guillaume V, Barateau V, Ong KC, Wong KT, Cosset FL, Horvat B, Salvetti A. 2013. Protection against henipavirus infection by use of recombinant adeno-associated virus-vector vaccines. J Infect Dis. 207(3):469–478. doi:10.1093/infdis/jis699
  • Porotto M, Rockx B, Yokoyama CC, Talekar A, DeVito I, Palermo LM, Liu J, Cortese R, Lu M, Feldmann H, et al. 2010. Inhibition of Nipah virus infection in vivo: targeting an early stage of Paramyxovirus fusion activation during viral entry. PLoS Pathog. 6(10):e1001168. doi:10.1371/journal.ppat.1001168
  • Posada D, Crandall KA. 1998. Modeltest: testing the model of DNA substitution. Bioinformatics. 14(9):817–818. doi:10.1093/bioinformatics/14.9.817
  • Prasad M, Lambe UP, Brar B, Shah I, Manimegalai J, Ranjan K, Rao R, Kumar S, Mahant S, Khurana SK, et al. 2018. Nanotherapeutics: an insight into healthcare and multi-dimensional applications in medical sector of the modern world. Biomed Pharmacother. 97:1521–1537. doi:10.1016/j.biopha.2017.11.026
  • Prescott J, de Wit E, Feldmann H, Munster VJ. 2012. The immune response to Nipah virus infection. Arch Virol. 157(9):1635–1641. doi:10.1007/s00705-012-1352-5
  • Prescott J, DeBuysscher BL, Feldmann F, Gardner DJ, Haddock E, Martellaro C, Scott D, Feldmann H. 2015. Single-dose live-attenuated vesicular stomatitis virus-based vaccine protects African green monkeys from Nipah virus disease. Vaccine. 33(24):2823–2829. doi:10.1016/j.vaccine.2015.03.089
  • Pulliam JRC, Epstein JH, Dushoff J, Rahman SA, Bunning M, Jamaluddin AA, Hyatt AD, Field HE, Dobson AP, Daszak P. 2012. Agricultural intensification, priming for persistence and the emergence of Nipah virus: a lethal bat-borne zoonosis. J Royal Soc Interface. 9(66):89–101. doi: 10.1098/rsif.2011.0223.
  • Rahman M, Chakraborty A, 2012. Nipah virus outbreaks in Bangladesh: a deadly infectious disease. WHO South East Asia J Public Health. 1(2):208–212. doi:10.4103/2224-3151.206933
  • Rahman MA, Hossain MJ, Sultana S, Homaira N, Khan SU, Rahman M, Gurley ES, Rollin PE, Lo MK, Comer JA, et al. 2012. Date palm sap linked to Nipah virus outbreak in Bangladesh, 2008. Vector Borne Zoonotic Dis. 12(1):65–72. doi:10.1089/vbz.2011.0656
  • Rahman SA, Hassan L, Epstein JH, Mamat ZC, Yatim AM, Hassan SS, Field HE, Hughes T, Westrum J, Naim MS, et al. 2013. Risk factors for Nipah virus infection among pteropid bats, Peninsular Malaysia. Emerg Infect Dis. 19(1):51–60. doi:10.3201/eid1901.120221
  • Ramphul K, Mejias SG, Agumadu VC, Sombans S, Sonaye R, Lohana P. 2018. The killer virus called Nipah: a review. Cureus. 10(8):e3168. doi: 10.7759/cureus.3168.
  • Ranadheera C, Proulx R, Chaiyakul M, Jones S, Grolla A, Leung A, Rutherford J, Kobasa D, Carpenter M, Czub M, 2018. The interaction between the Nipah virus nucleocapsid protein and phosphoprotein regulates virus replication. Sci Rep. 8(1):15994. doi:10.1038/s41598-018-34484-7
  • Ravichandran L, Venkatesan A, Febin Prabhu Dass J. 2018. Epitope-based immunoinformatics approach on RNA-dependent RNA polymerase (RdRp) protein complex of Nipah virus (NiV). J Cell Biochem. 2018 Nov 11. doi: 10.1002/jcb.27979. [Epub ahead of print]
  • Rawlinson SM, Zhao T, Rozario AM, Rootes CL, McMillan PJ, Purcell AW, Woon A, Marsh GA, Lieu KG, Wang LF, et al. 2018. Viral regulation of host cell biology by hijacking of the nucleolar DNA-damage response. Nat Commun. 9(1):3057. doi:10.1038/s41467-018-05354-7
  • Reynes JM, Counor D, Ong S, Faure C, Seng V, Molia S, Walston J, Georges-Courbot MC, Deubel V, Sarthou JL. 2005. Nipah virus in Lyle's flying foxes, Cambodia. Emerging Infect Dis. 11(7):1042–1047. doi:10.3201/eid1107.041350
  • Rizzardini G, Saporito T, Visconti A. 2018. What is new in infectious diseases: Nipah virus, MERS-CoV and the blueprint list of the World Health Organization. Infez Med. 26(3):195–198.
  • Rockx B, Bossart KN, Feldmann F, Geisbert JB, Hickey AC, Brining D, Callison J, Safronetz D, Marzi A, Kercher L, et al. 2010. A novel model of lethal Hendra virus infection in African green monkeys and the effectiveness of ribavirin treatment. J Virol. 84(19):9831–9839. doi:10.1128/JVI.01163-10
  • Rockx Brining D, Kramer J, Callison J, Ebihara H, Mansfield K, Feldmann H. 2011. Clinical outcome of henipavirus infection in hamsters is determined by the route and dose of infection. J Virol. 8:7658–7671. doi: 10.1128/JVI.00473-11
  • Rockx B, Winegar R, Freiberg AN. 2012. Recent progress in henipavirus research: molecular biology, genetic diversity, animal models. Antiviral Res. 95(2):135–149. doi:10.1016/j.antiviral.2012.05.008
  • Rodriguez JJ, Horvath CM. 2004. Host evasion by emerging paramyxoviruses: Hendra virus and Nipah virus v proteins inhibit interferon signalling. Viral Immunol. 17(2):210–219. doi:10.1089/0882824041310568
  • Rupprecht CE, Turmelle A, Kuzmin IV. 2011. A perspective on lyssavirus emergence and perpetuation. Curr Opin Virol. 1(6):662–670. doi:10.1016/j.coviro.2011.10.014
  • Saha CK, Mahbub Hasan M, Saddam Hossain M, Asraful Jahan M, Azad AK. 2017. In silico identification and characterization of common epitope-based peptide vaccine for Nipahand Hendra viruses. Asian Pac J Trop Med. 10(6):529–538. doi:10.1016/j.apjtm.2017.06.016
  • Saini S, Thakur CJ, Kumar V, Tandon S, Bhardwaj V, Maggar S, Namgyal S, Kaur G. 2018. Computational prediction of miRNAs in Nipah virus genome reveals possible interaction with human genes involved in encephalitis. Mol Biol Res Commun. 7(3):107–118. doi: 10.22099/mbrc.2018.29577.1322.
  • Sakib MS, Islam MR, Hasan AK, Nabi AH. 2014. Prediction of epitope-based peptides for the utility of vaccine development from fusion and glycoprotein of Nipah virus using in silico approach. Adv Bioinformatics. 1:402492. doi:10.1155/2014/402492
  • Sarma N. 2017. Emerging and re-emerging infectious diseases in South East Asia. Indian J Dermatol. 62(5):451–455. doi: 10.4103/ijd.IJD_389_17.
  • Satterfield BA, Cross RW, Fenton KA, Agans KN, Basler CF, Geisbert TW, Mire CE. 2015. The immunomodulating V and W proteins of Nipah virus determine disease course. Nat Commun. 6:7483. doi:10.1038/ncomms8483
  • Satterfield BA, Dawes BE, Milligan GN. 2016. Status of vaccine research and development of vaccines for Nipah virus. Vaccine. 34(26):2971–2975. doi:10.1016/j.vaccine.2015.12.075
  • Satterfield BA, Geisbert TW, Mire CE. 2016. Inhibition of the host antiviral response by Nipah virus: current understanding and future perspectives. Future Virol. 11(5):331–344. doi:10.2217/fvl-2016-0027
  • Satterfield BA. 2017. The future of preventing and treating Nipah virus infection. Future Sci. OA. 3(4):FSO220. doi:10.4155/fsoa-2017-0056
  • Sauerhering L, Zickler M, Elvert M, Behner L, Matrosovich T, Erbar S, Matrosovich M, Maisner A. 2016. Species-specific and individual differences in Nipah virus replication in porcine and human airway epithelial cells. J Gen Virol. 97(7):1511–1519. doi: 10.1099/jgv.0.000483.
  • Sauerhering L, Müller H, Behner L, Elvert M, Fehling SK, Strecker T, Maisner A. 2017. Variability of interferon-λ induction and antiviral activity in Nipah virus infected differentiated human bronchial epithelial cells of two human donors. J Gen Virol. 98(10):2447–2453. doi:10.1099/jgv.0.000934
  • Sazzad HMS, Jahangir Hossain M, Gurley ES, Ameen KMH, Parveen S, Saiful Islam M, Faruque LI, Podder G, Banu SS, Lo MK, et al. 2013. Nipah virus infection outbreak with nosocomial and corpse-to-human transmission, Bangladesh. Emerg Infect Dis. 19(2):210–217. doi:10.3201/eid1902.120971
  • Schountz T. 2014. Immunology of bats and their viruses: challenges and opportunities. Viruses. 6(12):4880–4901. doi:10.3390/v6124880
  • Schountz T, Baker ML, Butler J, Munster V. 2017. Immunological control of viral infections in Bbts and the emergence of viruses highly pathogenic to humans. Front Immunol. 8: 1098.
  • Seto J, Qiao L, Guenzel CA, Xiao S, Shaw ML, Hayot F, Sealfon SC. 2010. Novel Nipah virus immune-antagonism strategy revealed by experimental and computational study. J Virol. 84(21):10965–10973. doi:10.1128/JVI.01335-10
  • Sejvar JJ, Hossain J, Saha SK, Gurley ES, Banu S, Hamadani JD, Faiz MA, Siddiqui FM, Mohammad QD, Mollah AH, et al. 2007. Long-term neurological and functional outcome in Nipah virus infection. Ann Neurol. 62(3):235–242. doi:10.1002/ana.21178
  • Sendow I, Field HE, Curran J, Morrissy C, Meehan G, Buick T, Daniels P. 2006. Henipavirus in Pteropus vampyrus bats, Indonesia. Emerg Infect Dis. 12(4):711–712. doi:10.3201/eid1204.051181
  • Sendow I, Field HE, Adjid A, Ratnawati A, Breed AC, Darminto Morrissy C, Daniels P. 2010. Screening for Nipah virus infection in West Kalimantan Province, Indonesia. Zoonoses Public Health. 57(7–8):499–503. doi:10.1111/j.1863-2378.2009.01252.x
  • Sharma V, Kaushik S, Kumar R, Yadav JP, Kaushik S. 2018. Emerging trends of Nipah virus: a review. Rev Med Virol. 29(1):e2010. Sep 24: doi: 10.1002/rmv.2010.
  • Shaw ML. 2009. Henipaviruses employ a multifaceted approach to evade the antiviral interferon response. Viruses. 1(3):1190–1203. doi:10.3390/v1031190
  • Siddique AB, Fardows J, Farhana N, Mazumder M. 2016. Nipah Virus: a public health concern. J Enam Med Col. 6(2):101–105. 2:doi: http://dx.doi.org/10.3329/jemc.v6i2.27766. doi:10.3329/jemc.v6i2.27766
  • Simons RRL, Gale P, Horigan V, Snary EL, Breed AC. 2014. Potential for introduction of bat-borne zoonotic viruses into the EU: a review. Viruses. 6(5):2084–2121. doi:10.3390/v6052084
  • Singh RK, Dhama K, Malik YS, Ramakrishnan MA, Karthik K, Tiwari R, Saurabh S, Sachan S, Joshi SK. 2016. Zika virus - Emergence, evolution, pathology, diagnosis and control: current global scenario and future perspectives – a comprehensive review. Vet Quart. 36(3):150–175. doi:10.1080/01652176.2016.1188333
  • Singh RK, Dhama K, Malik YS, Ramakrishnan MA, Karthik K, Khandia R, Tiwari R, Munjal A, Saminathan M, Sachan S, et al. 2017. Ebola virus – epidemiology, diagnosis, and control: threat to humans, lessons learnt, and preparedness plans – an update on its 40 year’s journey. Vet Quart. 37(1):98–135. doi:10.1080/01652176.2017.1309474
  • Spiropoulou CF. 2018. Nipah virus outbreaks: still small but extremely lethal. J Infect Dis. doi: 10.1093/infdis/jiy611. [Epub ahead of print]
  • Stachowiak B, Weingartl HM. 2012. Nipah virus infects specific subsets of porcine peripheral blood mononuclear cells. PLoS One. 7(1):e30855. doi:10.1371/journal.pone.0030855
  • Steffen DL, Xu K, Nikolov DB, Broder CC. 2012. Henipavirus mediated membrane fusion, virus entry and targeted therapeutics. Viruses. 4(2):280–308. doi:10.3390/v4020280
  • Stone R. 2011. Epidemiology. Breaking the chain in Bangladesh. Science. 331(6021):1128–1131. doi:10.1126/science.331.6021.1128
  • Streatfield SJ, Kushnir N, Yusibov V. 2015. Plant-produced candidate countermeasures against emerging and reemerging infections and bioterror agents. Plant Biotechnol J. 13(8):1136–1159. doi:10.1111/pbi.12475
  • Sun B, Jia L, Liang B, Chen Q, Liu D. 2018. Phylogeography, transmission, and viral proteins of Nipah virus. Virol Sin. 33(5):385–393. doi: 10.1007/s12250-018-0050-1. [Epub ahead of print]
  • Sweileh WM. 2017. Global research trends of World Health Organization’s top eight emerging pathogens. Global Health. 13(1):9. doi:10.1186/s12992-017-0233-9
  • Tamura K, Stecher G, Peterson D, Filipski A, Kumar S. 2013. MEGA6: molecular evolutionary genetics analysis version 6.0. Mol Biol Evol. 30(12):2725–2729. doi:10.1093/molbev/mst197
  • Tan CT, Goh KJ, Wong KT, Sarji SA, Chua KB, Chew NK, Murugasu P, Loh YL, Chong HT, Tan KS, et al. 2002. Relapsed and late-onset Nipah encephalitis. Ann Neurol. 51(6):703–708., doi:10.1002/ana.10212
  • Tanimura N, Imada T, Kashiwazaki Y, Shahirudin S, Sharifah SH, Aziz AJ. 2004. Monoclonal antibody-based immunohistochemical diagnosis of Malaysian Nipah virus infection in pigs. J Comp Pathol. 131(2–3):199–206. doi:10.1016/j.jcpa.2004.03.006
  • Tekola B, Myers L, Lubroth J, Plee L, Calistri P, Pinto J. 2017. International health threats and global early warning and response mechanisms. Rev Sci Tech OIE.. 36(2):657–670. doi:10.20506/rst.36.2.2683
  • Ternhag A, Penttinen P. 2005. Nipah virus–another product from the Asian virus factory. Lakartidningen. 102(14):1046–1047.
  • Thibault PA, Watkinson RE, Moreira-Soto A, Drexler JF, Lee B. 2017. Zoonotic potential of emerging Paramyxoviruses: knowns and unknowns. Adv Virus Res. 98:1–55. doi:10.1016/bs.aivir.2016.12.001
  • Uchida S, Horie R, Sato H, Kai C, Yoneda M. 2018. Possible role of the Nipah virus V protein in the regulation of the interferon beta induction by interacting with UBX domain-containing protein-1. Sci Rep. 8(1):7682. doi:10.1038/s41598-018-25815-9
  • Uppal PK. 2000. Emergence of Nipah virus in Malaysia. Ann N Y Acad Sci. 916:354–357.
  • Vandali V, Biradar RB. 2018. Nipah virus (NiV) infection: a systematic review. JOJ Nursing & Health Care. 8(1):555729. doi: 10.19080/JOJNHC.2018.08.555729.
  • Vera-Velasco NM, García-Murria MJ, Sánchez Del Pino MM, Mingarro I, Martinez-Gil L. 2018. Proteomic composition of Nipah virus-like particles. J Proteomics. 172:190–200. doi:10.1016/j.jprot.2017.10.012
  • Vigant F, Lee B. 2011. Hendra and Nipah infection: pathology, models and potential therapies. Infect Disord Drug Targets. 11(3):315–336. doi:10.2174/187152611795768097
  • Wacharapluesadee S, Lumlertdacha B, Boongird K, Wanghongsa S, Chanhome L, Rollin P, Stockton P, Rupprecht CE, Ksiazek TG, Hemachudha T. 2005. Bat Nipah virus, Thailand. Emerging Infect Dis. 11(12):1949–1951. doi:10.3201/eid1112.050613
  • Wacharapluesadee S, Hemachudha T. 2007. Duplex nested RT-PCR for detection of Nipah virus RNA from urine specimens of bats. J Virol Methods. 141(1):97–101. doi:10.1016/j.jviromet.2006.11.023
  • Wacharapluesadee S, Boongird K, Wanghongsa S, Ratanasetyuth N, Supavonwong P, Saengsen D, Gongal GN, Hemachudha T. 2010. A longitudinal study of the prevalence of Nipah virus in Pteropus lylei bats in Thailand: evidence for seasonal preference in disease transmission. Vector Borne Zoonotic Dis. 10(2):183–190. doi:10.1089/vbz.2008.0105
  • Wahed F, Kader SA, Nessa A, Mahamud MM. 2011. Nipah virus: an emergent deadly Paramyxovirus infection in Bangladesh. J Bangladesh Soc Physiol. 6(2):134–139. doi: 10.3329/jbsp.v6i2.9764.
  • Walpita P, Barr J, Sherman M, Basler CF, Wang L. 2011. Vaccine potential of Nipah virus-like particles. PLoS One. 6(4):e18437. doi:10.1371/journal.pone.0018437
  • Walpita P, Cong Y, Jahrling PB, Rojas O, Postnikova E, Yu S, Johns L, Holbrook MR. 2017. A VLP-based vaccine provides complete protection against Nipah virus challenge following multiple-dose or single-dose vaccination schedules in a hamster model. NPJ Vaccines. 2:21. doi:10.1038/s41541-017-0023-7
  • Wang L, Harcourt BH, Yu M, Tamin A, Rota PA, Bellini WJ, Eaton BT. 2001. Molecular biology of Hendra and Nipah viruses. Microbes Infect. 3(4):279–287. doi:10.1016/S1286-4579(01)01381-8
  • Wang LF, Daniels P. 2012. Diagnosis of henipavirus infection: current capabilities and future directions. Curr Top Microbiol Immunol. 359:179–196.
  • Watkinson RE, Lee B. 2016. Nipah virus matrix protein: expert hacker of cellular machines. FEBS Lett. 590(15):2494–2511. doi:10.1002/1873-3468.12272
  • Weingartl H, Czub S, Copps J, Berhane Y, Middleton D, Marszal P, Gren J, Smith G, Ganske S, Manning L, Czub M. 2005. Invasion of the central nervous system in a porcine host by Nipah virus. J Virol. 79(12):7528–7534. doi:10.1128/JVI.79.12.7528-7534.2005
  • Weingartl HM, Berhane Y, Caswell JL, Loosmore S, Audonnet JC, Roth JA, Czub M. 2006. Recombinant Nipah virus vaccines protect pigs against challenge. J Virol. 80(16):7929–7938. doi:10.1128/JVI.00263-06
  • Weingartl HM, Berhane Y, Czub M. 2009. Animal models of henipavirus infection: a review. Vet J. 181(3):211–220. doi:10.1016/j.tvjl.2008.10.016
  • Wellehan JF, Jr, Green LG, Duke DG, Bootorabi S, Heard DJ, Klein PA, Jacobson ER. 2009. Detection of specific antibody responses to vaccination in variable flying foxes (Pteropus hypomelanus). Comp Immunol Microbiol Infect Dis. 32(5):379–394. doi:10.1016/j.cimid.2007.11.002
  • White JR, Boyd V, Crameri GS, Duch CJ, van LRK, Wang LF, Eaton BT. 2005. Location of, immunogenicity of and relationships between neutralization epitopes on the attachment protein (G) of Hendra virus. J Gen Virol. 86(10):2839–2848. doi:10.1099/vir.0.81218-0
  • Williamson MM, Torres-Velez FJ. 2010. Henipavirus: a review of laboratory animal pathology. Vet Pathol. 47(5):871–880. doi:10.1177/0300985810378648
  • Woeryadi S, Soeroso T. 1989. Japanese encephalitis in Indonesia. Southeast Asian J. Trop. Med. Public Health. 20:575–580.
  • Wong KT, Grosjean I, Brisson C, Blanquier B, Fevre-Montange M, Bernard A, Loth P, Georges-Courbot M-C, Chevallier M, Akaoka H, et al. 2003. A golden hamster model for human acute Nipah virus infection. Am. J. Pathology. 163(5):2127–2137. doi:10.1016/S0002-9440(10)63569-9
  • Wong KT, Robertson T, Ong BB, Chong JW, Yaiw KC, Wang LF, Ansford AJ, Tannenberg A. 2009. Human Hendra virus infection causes acute and relapsing encephalitis. Neuropathol Appl Neurobiol. 35(3):296–305. doi:10.1111/j.1365-2990.2008.00991.x
  • Wong KT, Ong KC. 2011. Pathology of acute Henipavirus infection in humans and animals. Pathol Res Int. 2011:567248. doi: 10.4061/2011/567248.
  • Wong JJW, Young TA, Zhang J, Liu S, Leser GP, Komives EA, Lamb RA, Zhou ZH, Salafsky J, Jardetzky TS. 2017. Monomeric ephrinB2 binding induces allosteric changes in Nipah virus G that precede its full activation. Nat Commun. 8(1):781. doi:10.1038/s41467-017-00863-3
  • Yadav PD, Raut CG, Shete AM, Mishra AC, Towner JS, Nichol ST, Mourya DT. 2012. Detection of Nipah virus RNA in fruit bat (Pteropus giganteus) from India. Am J Trop Med Hyg. 87(3):576–578. doi:10.4269/ajtmh.2012.11-0416
  • Yadav P, Sudeep A, Gokhale M, Pawar S, Shete A, Patil D, Kumar V, Lakra R, Sarkale P, Nichol S, Mourya D. 2018. Circulation of Nipah virus in Pteropus giganteus bats in northeast region of India, 2015. Indian J Med Res. 147(3):318–320. doi: 10.4103/ijmr.IJMR_1488_16.
  • Yob JM, Field H, Rashdi AM, Morrissy C, van der Heide B, Rota P, bin Adzhar A, White J, Daniels P, Jamaluddin A, Ksiazek T. 2001. Nipah virus infection in bats (order Chiroptera) in peninsular Malaysia. Emerging Infect Dis. 7(3):439–441. doi:10.3201/eid0703.017312
  • Yoneda M, Georges-Courbot MC, Ikeda F, Ishii M, Nagata N, Jacquot F, Raoul H, Sato H, Kai C. 2013. Recombinant measles virus vaccine expressing the Nipah virus glycoprotein protects against lethal Nipah virus challenge. PLoS One. 8(3):e58414. doi:10.1371/journal.pone.0058414
  • Yoneda M. 2014. Study of pathogenicity of Nipah virus and its vaccine development. Uirusu. 64(1):105–112. doi:10.2222/jsv.64.105
  • Yu F, Khairullah NS, Inoue S, Balasubramaniam V, Berendam SJ, Teh LK, Ibrahim NSW, Abdul Rahman S, Hassan SS, Hasebe F, et al. 2006. Serodiagnosis using recombinant Nipah virus nucleocapsid protein expressed in Escherichia coli. J Clin Microbiol. 44(9):3134–3138. doi:10.1128/JCM.00693-06
  • Yu J, Lv X, Yang Z, Gao S, Li C, Cai Y, Li J. 2018. The main risk factors of Nipah disease and its risk analysis in China. Viruses. 10(10):E572. doi: 10.3390/v10100572.
  • Yun T, Park A, Hill TE, Pernet O, Beaty SM, Juelich TL, Smith JK, Zhang L, Wang YE, Vigant F, et al. 2015. Efficient reverse genetics reveals genetic determinants of budding and fusogenic differences between Nipah and Hendra viruses and enables real-time monitoring of viral spread in small animal models of henipavirus infection. J Virol. 89(2):1242–1253. doi:10.1128/JVI.02583-14
  • Zhou P, Cowled C, Marsh GA, Shi Z, Wang LF, Baker ML. 2011. Type III IFN receptor expression and functional characterisation in the pteropid bat, Pteropus alecto. PLoS One. 6(9):e25385. doi:10.1371/journal.pone.0025385
  • Zhou P, Cowled C, Todd S, Crameri G, Virtue ER, Marsh GA, Klein R, Shi Z, Wang LF, Baker ML. 2011. Type III IFNs in pteropid bats: differential expression patterns provide evidence for distinct roles in antiviral immunity. J Immunol. 186(5):3138–3147. doi:10.4049/jimmunol.1003115
  • Zhou P, Tachedjian M, Wynne JW, Boyd V, Cui J, Smith I, Cowled C, Ng JH, Mok L, Michalski WP, et al. 2016. Contraction of the type I IFN locus and unusual constitutive expression of IFN-α in bats . Proc Natl Acad Sci U S A. 113(10):2696–2701. doi:10.1073/pnas.1518240113
  • Zumla A, Dar O, Kock R, Muturi M, Ntoumi F, Kaleebu P, Eusebio M, Mfinanga S, Bates M, Mwaba P, et al. 2016. Taking forward a 'One Health' approach for turning the tide against the Middle East respiratory syndrome coronavirus and other zoonotic pathogens with epidemic potential. Int J Infect Dis. 47:5–9. doi: 10.1016/j.ijid.2016.06.012.